Laparoscopic adjustable gastric banding for patients with body mass index of

Surg Obes Relat Dis

Division of Bariatric Surgery, New York University School of Medicine, New York, New York 10016, USA.

Published: January 2007

AI Article Synopsis

Article Abstract

Background: Many mild-to-moderately obese individuals (body mass index [BMI] 30-35 kg/m(2)) have serious diseases related to their obesity. Nonoperative therapy is ineffective in the long term, yet surgery has never been made widely available to this population.

Methods: Between 1996 and 2004, 93 patients with a BMI of 30-35 kg/m(2) underwent laparoscopic adjustable gastric banding with the LAP-BAND. All patients were referred by their primary physician, entered into a comprehensive bariatric surgery program at one Australian center, and operated on by one surgeon. Data on all patients were collected prospectively and entered into an electronic registry. The study parameters included preoperative age, gender, BMI, presence of co-morbidities, percentage of excess weight loss, and resolution of co-morbidities.

Results: The mean age was 44.6 years (range 16-76), mean weight was 98 kg, and the mean BMI was 32.7 kg/m(2) (range 30-34). Of the 93 patients, 42 (45%) had co-morbidities, including asthma, diabetes, hypertension, and sleep apnea. The proportion of patients in follow-up was 79%, 85%, and 89% at 1, 2, and 3 years, respectively. The mean weight was reduced to 71 kg at 1 year, 72 kg at 2 years, and 72 kg at 3 years. The mean BMI was reduced to 27.2 +/- 2.2, 27.3 +/- 3.1, and 27.6 +/- 3.7 kg/m(2), respectively, and the mean percentage of excess weight loss was 57.9% +/- 24.5%, 57.6 +/- 29.3%, and 53.8% +/- 32.8% at 1, 2, and 3 years, respectively. At 3 years, the BMI was 18-24 kg/m(2) in 34%, 25-29 kg/m(2) in 51%, and 30-35 kg/m(2) in 10%. At 3 years, the percentage of excess weight loss was <25% in 10%, 25-50% in 24%, 50-75% in 51%, and >75% in 10%. The co-morbidities improved or completely resolved in most patients. No mortality occurred.

Conclusion: We are very encouraged by this series of low BMI patients treated with the LAP-BAND. Their weight loss has been good, the complications have been minimal, and the co-morbidities have partially or wholly resolved. With additional study, it is reasonable to expect the weight guidelines for bariatric surgery to be altered to include patients with a BMI of 30-35 kg/m(2).

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soard.2006.07.005DOI Listing

Publication Analysis

Top Keywords

laparoscopic adjustable
4
adjustable gastric
4
gastric banding
4
banding patients
4
patients body
4
body mass
4
laparoscopic
1
gastric
1
banding
1
patients
1

Similar Publications

Gastric Stenosis Four Years After Adjustable Gastric Band Removal Surgery-A Video Case Report.

Obes Surg

December 2024

Division of Gastroenterology, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea.

Laparoscopic adjustable gastric banding (LAGB) is a type of bariatric surgery. Gastric stenosis or obstruction is a known complication of LAGB; however, its occurrence after band removal is extremely rare. A 60-year-old female, who had undergone LAGB 6 years earlier and band removal 4 years prior, presented to the hospital with recurrent vomiting.

View Article and Find Full Text PDF

Management of Post-RALP SUI and ED - What are and What Should we be Doing?

Curr Urol Rep

November 2024

Department of Urology, Indiana University, 11725 North Illinois Street - Carmel, Indianapolis, IN, IN - 46032, United States of America.

Article Synopsis
  • This review assesses the impact of robotic-assisted laparoscopic prostatectomy (RALP) on male stress urinary incontinence (SUI) and erectile dysfunction (ED), highlighting the significant quality-of-life challenges these conditions present.
  • It emphasizes the importance of patient history in determining treatment strategies, suggesting that penile rehabilitation may help improve erectile function post-surgery, though specific programs for optimal recovery are not yet agreed upon.
  • The review concludes that effective treatments for post-RALP SUI include both adjustable slings and artificial urinary sphincters, while future research should focus on enhancing treatment methods and patient compliance for better outcomes.
View Article and Find Full Text PDF

Obesity has been recognized as the main pandemic of this century. Multiple treatments have been developed: the use of medications, exercise, diet, and surgery. Bariatric surgery is one of the treatments that has shown the greatest effectiveness.

View Article and Find Full Text PDF

Background: Metabolic and bariatric surgery is a safe and effective treatment strategy for severe childhood obesity, affecting 10% of US adolescents.

Objectives: This prospective observational study addresses knowledge gaps related to changes in weight, cardiometabolic risk, and weight-related quality of life (WRQOL) in adolescents 10 years after laparoscopic adjustable gastric band (LAGB) insertion.

Setting: Five Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) US centers.

View Article and Find Full Text PDF

Background: Endoscopic bariatric surgery (EBS) is a new treatment for obesity. We compared the efficacy, safety, and probability of metabolic complications of different EBSs with laparoscopic sleeve gastrectomy (LSG).

Methods: This systematic review and network meta-analysis (NMA) included searches of PubMed, Web of Science, and the Cochrane Library from January 1, 2017, to December 27, 2022, to find comparative trials of EBS procedures and EBS with LSG.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!